Carta Biosciences believes that complex problems require computational solutions. By using cutting-edge systems biology and AI, they were able to reverse-engineer biology and also de-risk drug development programs at the earliest stages of drug development. Dr. CheeYang Chen, CEO, Carta Biosciences shares with us crucial healthcare issues and how artificial intelligence (AI) can be use to reverse disease and aging

<p>Carta Biosciences believes that complex problems require computational solutions. By using cutting-edge systems biology and AI, they were able to reverse-engineer biology and also de-risk drug development programs at the earliest stages of drug development.&nbsp;<strong>Dr. CheeYang Chen, CEO, Carta Biosciences</strong> shares with us crucial healthcare issues and how artificial intelligence (AI) can be use to reverse disease and aging</p>

Advertisement